Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Patients may soon be able to screen themselves for influenza using a simple, breathalyzer-type technology. The tool, developed by a professor in the Materials Science and Engineering Department…
Bacillus Calmette-Guérin (BCG) is an effective biologic therapy widely used in patients with non-muscle invasive bladder cancer. Sanofi recently announced their intent to discontinue BCG production, leaving Merck…
Julio A. Aguirre-Ghiso, PhD, Professor of Medicine, Hematology, and Medical Oncology at the Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, is leading a study on…
Neural networks (a.k.a. deep learning algorithms) can be used to teach computers to distinguish various types of disease via prior analysis of massive amounts of clinical data.
While influenza vaccination remains the top recommendation of physicians for protecting against the flu, there are other preventive measures that still need to become more widely adopted. Many…
Immunotherapy with newly developed “immune checkpoint inhibitors” has led to striking advances in treatment for aggressive malignancies such as melanoma, non-small cell lung cancer, and renal cell carcinoma.…
New research is helping scientists better understand gene modification’s effects on many forms of bladder cancer. Additionally, results from numerous recent studies seem to foreshadow a change of…
